ProfileGDS5822 / ILMN_2704134
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 76% 75% 72% 77% 75% 72% 74% 71% 76% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 188.176
GSM1276600PDAC Late Ablation Control 28675
GSM1276601PDAC Late Ablation Control 385.872
GSM1276602PDAC Late Ablation 1100.277
GSM1276603PDAC Late Ablation 288.575
GSM1276604PDAC Late Ablation 368.172
GSM1303940PDAC Late Ablation_anti-CTLA4 166.974
GSM1303941PDAC Late Ablation_anti-CTLA4 273.371
GSM1303942PDAC Late Ablation_anti-CTLA4 312476